Loading blog post…
A guide to GLP-1 weight loss injections (semaglutide, tirzepatide) offered at med spas — how they work, what to expect, compounded vs branded, candidacy, and the aesthetic intersection.
· By MedSpot Editorial · 5 min read
GLP-1 weight loss injections are the fastest-growing category at med spas — many practices now offer semaglutide or tirzepatide alongside their traditional aesthetic services. Here's what patients should know before starting, including the critical aesthetic implications.
GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes that produce significant weight loss as a primary or secondary effect. The two most relevant for weight management:
Semaglutide:
Tirzepatide:
How they work: These medications slow gastric emptying, reduce appetite centrally, and affect satiety signaling — the result is significantly reduced calorie intake with less effort. They are not stimulants.
GLP-1 programs at med spas typically involve:
The patient overlap is natural: Patients seeking weight loss and body contouring are the same patients med spas already serve. Offering medical weight management creates a complete body transformation service.
This is the most important distinction in the current market.
FDA-approved branded medications (Wegovy, Zepbound): Manufactured by Novo Nordisk and Eli Lilly respectively under rigorous FDA manufacturing standards. The reference products.
Compounded semaglutide/tirzepatide: Due to drug shortages, the FDA allowed compounding pharmacies to make copies of these medications. Compounded versions are:
2024 status: As the drug shortage designation ended, the FDA warned that compounded versions should no longer be made — though enforcement and practice lag. Many med spas continue to offer compounded versions at significantly lower prices.
Patient consideration: The risk profile difference between compounded and branded is not definitively characterized. However, patients should understand: lower price often means compounded formulation. Ask your provider explicitly what product they're dispensing.
Appropriate candidates:
Contraindications:
Important: At a med spa with appropriate medical oversight, a physician or NP should take a full medical history before prescribing. A prescription without medical evaluation is inappropriate.
Weeks 1–4: Dose escalation begins at a low dose to minimize GI side effects. Weight loss is modest at this phase — the body is adjusting.
Months 2–4: Appetite reduction becomes significant. Most patients notice a "food noise" reduction — the constant background thinking about food diminishes. Weight loss accelerates.
Months 4–12: Maximal weight loss phase for most patients. At Wegovy's target dose (2.4 mg semaglutide weekly), most weight loss is achieved by 12–16 months.
Ongoing: Maintenance dosing. Weight tends to return when medication is stopped — these are chronic condition treatments, not courses.
Common (especially during dose escalation):
Less common but notable:
Serious (rare):
Significant weight loss — from any cause — can cause facial volume loss. GLP-1 medications produce this at scale because of rapid, substantial weight reduction. Patients lose fat from facial fat compartments, which can make them look older, gaunt, or hollow-cheeked even as their body looks better.
Key aesthetic intersections:
Filler during weight loss: Not recommended. The face keeps changing as you lose weight. Filler placed while losing weight may look overcorrected as the face continues to thin. Wait until weight has been stable for 3–6 months before booking filler appointments.
Filler after weight loss plateau: This is the correct timing. Voluma for cheeks, temple filler, or a liquid facelift approach to restore facial volume after the weight loss phase is complete is often the most efficient sequence.
Body sculpting timing: Same principle — body contouring treatments (CoolSculpting, Emsculpt) should wait until weight has been stable for 3–6 months. During active loss, the treatment area keeps changing.
Skin laxity: Significant weight loss can leave loose skin on the face, neck, abdomen, and thighs. Skin tightening devices (Morpheus8, Ultherapy) and potentially surgery are considerations after plateauing.
Looking for a med spa offering medical weight management? Browse body treatment providers on MedSpot →